A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management

Gro Dahlseng Håkonsen, Ann Lisbeth Torbergsen, Petra Strelec, Derna Campbell, S. Hudson, T. Loennechen

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring quality of drug use in chronic pain management in relation to guideline standards, and has been developed and tested in Norway with UK collaboration. The present paper describes the revision of the assessment tool for use in the UK, and its subsequent validation. Setting Three hospitals and one hospice in Scotland, UK. The MAT-CP was field-tested to produce preliminary data on its applicability in a UK clinical setting. The tool was then modified by peer review among clinical specialists before and after a pilot. The revised tool was further validated by wider application to a study sample of cancer inpatients. The outcome was the evaluation of the tool's utility in relation to clinical documentation in terms of applicability, clarity, reliability and perceived relevance of each criterion. The findings also included a quantification of adherence to the guideline criteria. The revised tool comprised 37 criteria covering six different aspects of cancer pain management. The field testing and pilot informed the modification of the MAT-CP to optimise its clarity and utility when applied to patients' clinical documentation. The revised tool was tested on 101 cancer patients experiencing pain (56 males), mean (standard deviation) age 68.9 (13.5) years. Overall guideline adherence was 68% (n = 1850 applicable criteria). Good inter-rater reliability (Cohen's kappa κ = 0.92) was demonstrated in the application. The preliminary application of the tool during validation and field-testing has highlighted several issues for further study. A clinical tool to examine prescribing in cancer pain management that was designed for use in Norway has been revised for use in UK clinical settings. Reliability, face and content validity have been informed by applying the tool to patient data in clinical settings.
LanguageEnglish
Pages99-107
Number of pages8
JournalInternational Journal of Pharmacy Practice
Volume16
Issue number2
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Medication Adherence
Pain Management
Guidelines
Guideline Adherence
Norway
Documentation
Hospices
Peer Review
Scotland
Reproducibility of Results
Chronic Pain
Cancer Pain
Inpatients
Neoplasms
Pain
Testing
Pharmaceutical Preparations

Keywords

  • medication assessment tool
  • medication
  • cancer
  • pain management
  • pharmacology

Cite this

Håkonsen, Gro Dahlseng ; Torbergsen, Ann Lisbeth ; Strelec, Petra ; Campbell, Derna ; Hudson, S. ; Loennechen, T. / A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. In: International Journal of Pharmacy Practice. 2008 ; Vol. 16, No. 2. pp. 99-107.
@article{51ba42995d3a4158b8638ca5c48de18b,
title = "A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management",
abstract = "The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring quality of drug use in chronic pain management in relation to guideline standards, and has been developed and tested in Norway with UK collaboration. The present paper describes the revision of the assessment tool for use in the UK, and its subsequent validation. Setting Three hospitals and one hospice in Scotland, UK. The MAT-CP was field-tested to produce preliminary data on its applicability in a UK clinical setting. The tool was then modified by peer review among clinical specialists before and after a pilot. The revised tool was further validated by wider application to a study sample of cancer inpatients. The outcome was the evaluation of the tool's utility in relation to clinical documentation in terms of applicability, clarity, reliability and perceived relevance of each criterion. The findings also included a quantification of adherence to the guideline criteria. The revised tool comprised 37 criteria covering six different aspects of cancer pain management. The field testing and pilot informed the modification of the MAT-CP to optimise its clarity and utility when applied to patients' clinical documentation. The revised tool was tested on 101 cancer patients experiencing pain (56 males), mean (standard deviation) age 68.9 (13.5) years. Overall guideline adherence was 68{\%} (n = 1850 applicable criteria). Good inter-rater reliability (Cohen's kappa κ = 0.92) was demonstrated in the application. The preliminary application of the tool during validation and field-testing has highlighted several issues for further study. A clinical tool to examine prescribing in cancer pain management that was designed for use in Norway has been revised for use in UK clinical settings. Reliability, face and content validity have been informed by applying the tool to patient data in clinical settings.",
keywords = "medication assessment tool, medication, cancer, pain management, pharmacology",
author = "H{\aa}konsen, {Gro Dahlseng} and Torbergsen, {Ann Lisbeth} and Petra Strelec and Derna Campbell and S. Hudson and T. Loennechen",
year = "2008",
month = "4",
doi = "10.1211/ijpp.16.2.0007",
language = "English",
volume = "16",
pages = "99--107",
journal = "International Journal of Pharmacy Practice",
issn = "0961-7671",
number = "2",

}

A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. / Håkonsen, Gro Dahlseng; Torbergsen, Ann Lisbeth; Strelec, Petra; Campbell, Derna; Hudson, S.; Loennechen, T.

In: International Journal of Pharmacy Practice, Vol. 16, No. 2, 04.2008, p. 99-107.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management

AU - Håkonsen, Gro Dahlseng

AU - Torbergsen, Ann Lisbeth

AU - Strelec, Petra

AU - Campbell, Derna

AU - Hudson, S.

AU - Loennechen, T.

PY - 2008/4

Y1 - 2008/4

N2 - The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring quality of drug use in chronic pain management in relation to guideline standards, and has been developed and tested in Norway with UK collaboration. The present paper describes the revision of the assessment tool for use in the UK, and its subsequent validation. Setting Three hospitals and one hospice in Scotland, UK. The MAT-CP was field-tested to produce preliminary data on its applicability in a UK clinical setting. The tool was then modified by peer review among clinical specialists before and after a pilot. The revised tool was further validated by wider application to a study sample of cancer inpatients. The outcome was the evaluation of the tool's utility in relation to clinical documentation in terms of applicability, clarity, reliability and perceived relevance of each criterion. The findings also included a quantification of adherence to the guideline criteria. The revised tool comprised 37 criteria covering six different aspects of cancer pain management. The field testing and pilot informed the modification of the MAT-CP to optimise its clarity and utility when applied to patients' clinical documentation. The revised tool was tested on 101 cancer patients experiencing pain (56 males), mean (standard deviation) age 68.9 (13.5) years. Overall guideline adherence was 68% (n = 1850 applicable criteria). Good inter-rater reliability (Cohen's kappa κ = 0.92) was demonstrated in the application. The preliminary application of the tool during validation and field-testing has highlighted several issues for further study. A clinical tool to examine prescribing in cancer pain management that was designed for use in Norway has been revised for use in UK clinical settings. Reliability, face and content validity have been informed by applying the tool to patient data in clinical settings.

AB - The medication assessment tool for cancer pain management (MAT-CP) is a novel tool for measuring quality of drug use in chronic pain management in relation to guideline standards, and has been developed and tested in Norway with UK collaboration. The present paper describes the revision of the assessment tool for use in the UK, and its subsequent validation. Setting Three hospitals and one hospice in Scotland, UK. The MAT-CP was field-tested to produce preliminary data on its applicability in a UK clinical setting. The tool was then modified by peer review among clinical specialists before and after a pilot. The revised tool was further validated by wider application to a study sample of cancer inpatients. The outcome was the evaluation of the tool's utility in relation to clinical documentation in terms of applicability, clarity, reliability and perceived relevance of each criterion. The findings also included a quantification of adherence to the guideline criteria. The revised tool comprised 37 criteria covering six different aspects of cancer pain management. The field testing and pilot informed the modification of the MAT-CP to optimise its clarity and utility when applied to patients' clinical documentation. The revised tool was tested on 101 cancer patients experiencing pain (56 males), mean (standard deviation) age 68.9 (13.5) years. Overall guideline adherence was 68% (n = 1850 applicable criteria). Good inter-rater reliability (Cohen's kappa κ = 0.92) was demonstrated in the application. The preliminary application of the tool during validation and field-testing has highlighted several issues for further study. A clinical tool to examine prescribing in cancer pain management that was designed for use in Norway has been revised for use in UK clinical settings. Reliability, face and content validity have been informed by applying the tool to patient data in clinical settings.

KW - medication assessment tool

KW - medication

KW - cancer

KW - pain management

KW - pharmacology

UR - http://dx.doi.org/10.1211/ijpp.16.2.0007

U2 - 10.1211/ijpp.16.2.0007

DO - 10.1211/ijpp.16.2.0007

M3 - Article

VL - 16

SP - 99

EP - 107

JO - International Journal of Pharmacy Practice

T2 - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

SN - 0961-7671

IS - 2

ER -